Zobrazeno 1 - 10
of 428
pro vyhledávání: '"du Bois, A"'
Publikováno v:
Journal of Occupational Health
JOURNAL OF OCCUPATIONAL HEALTH
JOURNAL OF OCCUPATIONAL HEALTH
Objectives Motivation for return to work (RTW) reflects the degree of willingness to resume work activities and has been shown to be a crucial factor in long-term work disability. The satisfaction of basic psychological needs and motivation as descri
Autor:
Enrico Vizza, Sonia Magni, Beyhan Ataseven, Vito Chiantera, Nicolò Bizzarri, Philipp Harter, Daniela Giuliani, Anna Fagotti, Debora Ferrari, Anna Myriam Perrone, Pierandrea De Iaco, Francesca De Felice, Jvan Casarin, Andreas du Bois, Robert Fruscio, Giacomo Corrado, Mareike Bommert, Giovanni Scambia, Stefano Cianci
Objective: The therapeutic role of pelvic and para-aortic lymphadenectomy in surgical staging of apparent early-stage epithelial ovarian cancer (eEOC) is still under debate. The aim of this study was to evaluate the potential therapeutic role of syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20118a1f853b9e3f6845eb7d6ef4fd46
http://hdl.handle.net/11585/810972
http://hdl.handle.net/11585/810972
Autor:
Yukio Sonoda, Annalisa Garbi, Mikkel Rosendahl, Ginger J. Gardner, Saurabh Phadnis, Alexander Traut, Thaïs Baert, Andreas du Bois, Giovanni Damiano Aletti, Dennis S. Chi, Jan Philipp Ramspott, Stefan Kommoss, Carrie L. Langstraat, Philipp Harter, Mustafa Zelal Muallem, Helmut Plett, Olga T. Filippova, Florin Andrei Taran, Kara Long Roche, Oliver Zivanovic
Publikováno v:
Gynecol Oncol
Background Standard of care in patients with advanced ovarian cancer (AOC) is upfront surgery followed by chemotherapy. Neoadjuvant chemotherapy (NACT) and interval debulking surgery (IDS) is an alternative in selected patients. Most data exist with
Autor:
IM Bover Barcelo, Jørn Herrstedt, P. Wang, Dominique Berton-Rigaud, Bobbie J. Rimel, A. du Bois, Sven Mahner, Mansoor Raza Mirza, F.A. de Jong, Elsa Kalbacher, Divya Gupta, Ignace Vergote, Benedict B. Benigno, Anne Dørum, Domenica Lorusso, Paul Bessette, Joseph Buscema, S. Lau, Ursula A. Matulonis, A. Casado Herráez, Jonathan A. Ledermann, Tally Levy
Publikováno v:
Mirza, M R, Benigno, B, Dørum, A, Mahner, S, Bessette, P, Barceló, I B, Berton-Rigaud, D, Ledermann, J A, Rimel, B J, Herrstedt, J, Lau, S, du Bois, A, Herráez, A C, Kalbacher, E, Buscema, J, Lorusso, D, Vergote, I, Levy, T, Wang, P, de Jong, F A, Gupta, D & Matulonis, U A 2020, ' Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo : Results from the phase III ENGOT-OV16/NOVA trial ', Gynecologic Oncology, vol. 159, no. 2, pp. 442-448 . https://doi.org/10.1016/j.ygyno.2020.09.006
OBJECTIVE: Niraparib is a poly(ADP-ribose) polymerase (PARP) inhibitor approved for use in heavily pretreated patients and as maintenance treatment in patients with newly-diagnosed or recurrent ovarian cancer following a response to platinum-based ch
Autor:
Peter Hillemanns, Alexander Reuss, Michaela Bossart, Jalid Sehouli, Ulrich Petry, Antje Belau, Andreas du Bois, Felix Hilpert, Annette Hasenburg, Martina Gropp-Meier, Volker Hanf, Barbara Schmalfeld, Sven Mahner, Philipp Harter, Bjoern Lampe, Elfriede Greimel, Uwe Herwig, Uwe Wagner
Publikováno v:
International Journal of Gynecologic Cancer. 30:1548-1553
BackgroundThere is limited information about the impact of radical surgery including pelvic and para-aortic lymphadenectomy and subsequent platinum-based chemotherapy on sexuality in patients with advanced ovarian cancer.ObjectiveTo evaluate the impa
Autor:
Harter, Philipp, Sehouli, Jalid, Vergote, Ignace, Ferron, Gwenael, Reuss, Alexander, Meier, Werner, Greggi, Stefano, Mosgard, Berit J, Selle, Frederic, Guyon, Frédéric, Pomel, Christophe, Lécuru, Fabrice, Zang, Rongyu, Avall-Lundqvist, Elisabeth, Kim, Jae-Weon, Ponce, Jordi, Raspagliesi, Francesco, Kristensen, Gunnar, Classe, Jean-Marc, Hillemanns, Peter, Jensen, Pernille, Hasenburg, Annette, Ghaem-Maghami, Sadaf, Mirza, Mansoor R, Lund, Bente, Reinthaller, Alexander, Santaballa, Ana, Olaitan, Adeola, Hilpert, Felix, du Bois, Andreas, S Buchholz, A Burges, U Canzler, D Denschlag, A El-Balat, G Emons, R Felberbaum, N de Gregorio, M Gropp-Meier, V Hanf, L Hanker, R Hils, C Kurzeder, B Lampe, A Mustea, M Schmidt, R Schutz, M Weigel, S Weiser, A Zorr, C Marth, E Petru, T Scholl, M Beltran, I Bover, A Gomez di Laino, N Lainez, S Martinez, A Poveda Velasco, M Romeo, H Crouet, E de Gournay, G Deplanque, P Follana, A Floquet, D Lanvin, J Leveque, E Pujade-Lauraine, N Raban, B Resch, A M Savoye, G Aletti, G Giorda, F Landoni, C Scaffa, J Abu, F Alexander-Sefre, D Barton, S Butler-Manuel, R Clayton, R Crawford, T Duncan, A El-Ghobashy, C Fotopoulou, M Hall, C Intrivici, A Lawrence, D Luesley, R Naik, A Nordin, J Tidy, L Fokdahl, A Hofsjö, P Kjolhede, B Eyjolfsdottir, Z Y Dai, P Zhang, B Aminossadati, M Hahmann, C Nasemann, S Yahiaoui, M Wittenberg, C Schade-Brittinger, G Elser, D Reddig, M Kuncke, S Polleis, Y Mattukat, A Riha, R Berger, J de Roover, B Kaur, J Crook, F Nepote, B Votan, M Andriamamonjy, J Bryce, S Ristinge
Publikováno v:
Harter, P, Sehouli, J, Vergote, I, Ferron, G, Reuss, A, Meier, W, Greggi, S, Mosgard, B J, Selle, F, Guyon, F, Pomel, C, Lécuru, F, Zang, R, Avall-Lundqvist, E, Kim, J-W, Ponce, J, Raspagliesi, F, Kristensen, G, Classe, J-M, Hillemanns, P, Jensen, P, Hasenburg, A, Ghaem-Maghami, S, Mirza, M R, Lund, B, Reinthaller, A, Santaballa, A, Olaitan, A, Hilpert, F, du Bois, A & DESKTOP III Investigators 2021, ' Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer ', The New England Journal of Medicine, vol. 385, no. 23, pp. 2123-2131 . https://doi.org/10.1056/NEJMoa2103294
NEW ENGLAND JOURNAL OF MEDICINE
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Harter, P, Sehouli, J, Vergote, I, Ferron, G, Reuss, A, Meier, W, Greggi, S, Mosgard, B J, Selle, F, Guyon, F, Pomel, C, Lécuru, F, Zang, R, Avall-Lundqvist, E, Kim, J W, Ponce, J, Raspagliesi, F, Kristensen, G, Classe, J M, Hillemanns, P, Jensen, P, Hasenburg, A, Ghaem-Maghami, S, Mirza, M R, Lund, B, Reinthaller, A, Santaballa, A, Olaitan, A, Hilpert, F & Du Bois, A 2021, ' Randomized trial of cytoreductive surgery for relapsed ovarian cancer ', New England Journal of Medicine, vol. 385, no. 23, pp. 2123-2131 . https://doi.org/10.1056/NEJMoa2103294
NEW ENGLAND JOURNAL OF MEDICINE
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Harter, P, Sehouli, J, Vergote, I, Ferron, G, Reuss, A, Meier, W, Greggi, S, Mosgard, B J, Selle, F, Guyon, F, Pomel, C, Lécuru, F, Zang, R, Avall-Lundqvist, E, Kim, J W, Ponce, J, Raspagliesi, F, Kristensen, G, Classe, J M, Hillemanns, P, Jensen, P, Hasenburg, A, Ghaem-Maghami, S, Mirza, M R, Lund, B, Reinthaller, A, Santaballa, A, Olaitan, A, Hilpert, F & Du Bois, A 2021, ' Randomized trial of cytoreductive surgery for relapsed ovarian cancer ', New England Journal of Medicine, vol. 385, no. 23, pp. 2123-2131 . https://doi.org/10.1056/NEJMoa2103294
BACKGROUND: Treatment for patients with recurrent ovarian cancer has been mainly based on systemic therapy. The role of secondary cytoreductive surgery is unclear. METHODS: We randomly assigned patients with recurrent ovarian cancer who had a first r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9f31361614653d123d3ce643aeba6c3
https://vbn.aau.dk/da/publications/7ebaa8eb-4c70-44c3-82d4-fe478c1c7475
https://vbn.aau.dk/da/publications/7ebaa8eb-4c70-44c3-82d4-fe478c1c7475
Autor:
Carsten, Denkert, Marcel, Romey, Brad, Swedlund, Akira, Hattesohl, Julia, Teply-Szymanski, Stefan, Kommoss, Kristin, Kaiser, Annette, Staebler, Andreas, du Bois, Albert, Grass, Christiane, Knappmeyer, Florian, Heitz, Cara, Solimeno, Thomas, Ebel, Philipp, Harter, Frederik, Marmé, Paul, Jank, Timo, Gaiser, Chris, Neff, Uwe, Wagner, Kirsten M, Timms, Fiona, Rodepeter
Publikováno v:
The Journal of molecular diagnostics : JMD. 24(12)
The diagnostic evaluation of homologous recombination deficiency (HRD) is central to define targeted therapy strategies for patients with ovarian carcinoma. We evaluated HRD in 514 ovarian carcinoma samples by next-generation sequencing of DNA librar
Autor:
Eric Boetel, Andreas du Bois, Matthias W. Beckmann, Mareike Bommert, Peter Dall, Thomas B. Hildebrandt, Janine Ahlfaenger
Publikováno v:
Archives of Gynecology and Obstetrics. 301:1513-1519
Despite the introduction of sentinel node biopsy in patients with vulvar cancer, still approximately 50% of all patients have to undergo an inguinofemoral lymphadenectomy. This is associated with a high incidence of postoperative complications, which
Autor:
Jalid Sehouli, Martina Gropp-Meier, Behnaz Aminossadati, Nikolaus de Gregorio, Alexander Burges, Ulrich Canzler, Ahmed El-Balat, Barbara Schmalfeldt, Annette Hasenburg, Pauline Wimberger, Christian Jackisch, Uwe Wagner, Philipp Harter, Petra Neuser, Hans-Joachim Lück, Andreas du Bois, Werner Meier, Sven Mahner, Jacobus Pfisterer, Stefan Kommoss
Publikováno v:
Archives of Gynecology and Obstetrics. 301:1267-1274
Although thrombocytosis in patients with primary ovarian cancer has been widely investigated, there are only very few data about the role of thrombocytosis in recurrent ovarian cancer. The aim of our study was to investigate the impact of pretreatmen
Autor:
Stephanie Schneider, Caroline Vogt, Mattea Reinisch, Johanna Frindte, Vincenzo Bluni, Sonia Prader, Gudrun Gebers, Sherko Kuemmel, Mareike Bommert, Alexander Traut, Elisabeth Breit, Philipp Harter, Andreas du Bois, Athina Kostara, Beyhan Ataseven, Florian Heitz
Publikováno v:
Supportive Care in Cancer. 28:3605-3615
Due to advances in anticancer treatment and supportive care, patients increasingly complained about nonphysical side effects of chemotherapy and targeted therapy in recent years. Therefore, continuous assessment of side effects and patients’ percep